Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Preformulation Intermediates industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer Inc
Sanofi
Teva Pharmaceutical Industries Ltd
Merck & Co
Boehringer Ingelheim
Eli Lilly and Company
AstraZeneca Plc
AbbVie
Mylan, Inc
Novartis International AG
By Type:
Chemical API
Biological API
By Application:
Cardiovascular Drugs
Neurology Drugs
Others
Musculoskeletal Drugs
Oncology Drugs
Non-steroidal Anti-inflammatory Drugs
Anti-diabetic Drugs
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Preformulation Intermediates Market Overview 2018-2029
-
1.1 China Preformulation Intermediates Industry Development Overview
-
1.2 China Preformulation Intermediates Industry Development History
-
1.3 China Preformulation Intermediates Industry Market Size (2018-2029)
-
1.4 China Preformulation Intermediates Market Analysis by Type from Production Side
-
1.4.1 China Preformulation Intermediates Production Volume, Production Value and Growth Rate of Chemical API (2018-2029)
-
1.4.2 China Preformulation Intermediates Production Volume, Production Value and Growth Rate of Biological API (2018-2029)
-
1.5 China Preformulation Intermediates Market Analysis by Application from Consumption End
-
1.5.1 China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Cardiovascular Drugs (2018-2029)
-
1.5.2 China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Neurology Drugs (2018-2029)
-
1.5.3 China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.4 China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Musculoskeletal Drugs (2018-2029)
-
1.5.5 China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Oncology Drugs (2018-2029)
-
1.5.6 China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Non-steroidal Anti-inflammatory Drugs (2018-2029)
-
1.5.7 China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Anti-diabetic Drugs (2018-2029)
-
1.6 China Preformulation Intermediates Market Analysis by Region
-
1.6.1 North China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
Chapter 2 China Preformulation Intermediates Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Preformulation Intermediates Market Status and Competition at home and abroad in 2023
-
2.2.2 China Preformulation Intermediates Market Status and Competition Analysis in 2023
-
2.2.3 China Preformulation Intermediates Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Preformulation Intermediates Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Preformulation Intermediates Industry Development
Chapter 3 Preformulation IntermediatesIndustry Chain Analysis
-
3.1 Preformulation Intermediates Industry Chain
-
3.2 Preformulation Intermediates Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Preformulation Intermediates Market
-
3.3 Preformulation Intermediates Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Preformulation Intermediates Market
Chapter 4 China Preformulation Intermediates Market, by Type
-
4.1 China Preformulation Intermediates Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Preformulation Intermediates Total Production Volume and Growth Rate from Production Side
-
4.5 China Preformulation Intermediates Production Volume and Growth Rate, by Type
-
4.5.1 China Preformulation Intermediates Production Volume and Growth Rate of Chemical API
-
4.5.2 China Preformulation Intermediates Production Volume and Growth Rate of Biological API
Chapter 5 China Preformulation Intermediates Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Preformulation Intermediates Total Market Size and Growth Rate from Consumption End
-
5.5 China Preformulation Intermediates Market Size and Growth Rate, by Application
-
5.5.1 China Preformulation Intermediates Market Size and Growth Rate of Cardiovascular Drugs
-
5.5.2 China Preformulation Intermediates Market Size and Growth Rate of Neurology Drugs
-
5.5.3 China Preformulation Intermediates Market Size and Growth Rate of Others
-
5.5.4 China Preformulation Intermediates Market Size and Growth Rate of Musculoskeletal Drugs
-
5.5.5 China Preformulation Intermediates Market Size and Growth Rate of Oncology Drugs
-
5.5.6 China Preformulation Intermediates Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs
-
5.5.7 China Preformulation Intermediates Market Size and Growth Rate of Anti-diabetic Drugs
Chapter 6 China Preformulation Intermediates Market, by Region
-
6.1 China Preformulation Intermediates Production Volume and Production Value, by Region
-
6.2 China Preformulation Intermediates Sales Volume and Sales Value, by Region
Chapter 7 North China Preformulation Intermediates Market Analysis
-
7.1 North China Preformulation Intermediates Market, by Type
-
7.2 North China Preformulation Intermediates Market, by Application
Chapter 8 Central China Preformulation Intermediates Market Analysis
-
8.1 Central China Preformulation Intermediates Market, by Type
-
8.2 Central China Preformulation Intermediates Market, by Application
Chapter 9 South China Preformulation Intermediates Market Analysis
-
9.1 South China Preformulation Intermediates Market, by Type
-
9.2 South China Preformulation Intermediates Market, by Application
Chapter 10 East China Preformulation Intermediates Market Analysis
-
10.1 East China Preformulation Intermediates Market, by Type
-
10.2 East China Preformulation Intermediates Market, by Application
Chapter 11 Northeast China Preformulation Intermediates Market Analysis
-
11.1 Northeast China Preformulation Intermediates Market, by Type
-
11.2 Northeast China Preformulation Intermediates Market, by Application
Chapter 12 Southwest China Preformulation Intermediates Market Analysis
-
12.1 Southwest China Preformulation Intermediates Market, by Type
-
12.2 Southwest China Preformulation Intermediates Market, by Application
Chapter 13 Northwest China Preformulation Intermediates Market Analysis
-
13.1 Northwest China Preformulation Intermediates Market, by Type
-
13.2 Northwest China Preformulation Intermediates Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer Inc
-
14.1.1 Pfizer Inc Company Profile
-
14.1.2 Pfizer Inc Preformulation Intermediates Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Sanofi
-
14.2.1 Sanofi Company Profile
-
14.2.2 Sanofi Preformulation Intermediates Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Teva Pharmaceutical Industries Ltd
-
14.3.1 Teva Pharmaceutical Industries Ltd Company Profile
-
14.3.2 Teva Pharmaceutical Industries Ltd Preformulation Intermediates Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Merck & Co
-
14.4.1 Merck & Co Company Profile
-
14.4.2 Merck & Co Preformulation Intermediates Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Profile
-
14.5.2 Boehringer Ingelheim Preformulation Intermediates Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Eli Lilly and Company
-
14.6.1 Eli Lilly and Company Company Profile
-
14.6.2 Eli Lilly and Company Preformulation Intermediates Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 AstraZeneca Plc
-
14.7.1 AstraZeneca Plc Company Profile
-
14.7.2 AstraZeneca Plc Preformulation Intermediates Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 AbbVie
-
14.8.1 AbbVie Company Profile
-
14.8.2 AbbVie Preformulation Intermediates Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Mylan, Inc
-
14.9.1 Mylan, Inc Company Profile
-
14.9.2 Mylan, Inc Preformulation Intermediates Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Novartis International AG
-
14.10.1 Novartis International AG Company Profile
-
14.10.2 Novartis International AG Preformulation Intermediates Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Preformulation Intermediates Industry Research Conclusions
-
15.2 Preformulation Intermediates Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Preformulation Intermediates Industry Market Size (2018-2029)
-
Figure China Preformulation Intermediates Production Volume, Production Value and Growth Rate of Chemical API (2018-2029)
-
Figure China Preformulation Intermediates Production Volume, Production Value and Growth Rate of Biological API (2018-2029)
-
Figure China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Cardiovascular Drugs (2018-2029)
-
Figure China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Neurology Drugs (2018-2029)
-
Figure China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Musculoskeletal Drugs (2018-2029)
-
Figure China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Oncology Drugs (2018-2029)
-
Figure China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Non-steroidal Anti-inflammatory Drugs (2018-2029)
-
Figure China Preformulation Intermediates Sales Volume, Sales Value and Growth Rate of Anti-diabetic Drugs (2018-2029)
-
Figure North China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
Figure Central China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
Figure South China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
Figure East China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Preformulation Intermediates Market Size and Growth Rate from 2018-2029
-
Figure Preformulation Intermediates Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Preformulation Intermediates Market Share by Type in 2018
-
Figure China Preformulation Intermediates Market Share by Type in 2023
-
Figure China Preformulation Intermediates Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Preformulation Intermediates Production Volume and Growth Rate of Chemical API (2018-2023)
-
Figure China Preformulation Intermediates Production Volume and Growth Rate of Biological API (2018-2023)
-
Figure China Preformulation Intermediates Market Share by Application in 2018
-
Figure China Preformulation Intermediates Market Share by Application in 2023
-
Figure China Preformulation Intermediates Total Market Size and Growth Rate from Consumption End
-
Figure China Preformulation Intermediates Market Size and Growth Rate of Cardiovascular Drugs (2018-2023)
-
Figure China Preformulation Intermediates Market Size and Growth Rate of Neurology Drugs (2018-2023)
-
Figure China Preformulation Intermediates Market Size and Growth Rate of Others (2018-2023)
-
Figure China Preformulation Intermediates Market Size and Growth Rate of Musculoskeletal Drugs (2018-2023)
-
Figure China Preformulation Intermediates Market Size and Growth Rate of Oncology Drugs (2018-2023)
-
Figure China Preformulation Intermediates Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs (2018-2023)
-
Figure China Preformulation Intermediates Market Size and Growth Rate of Anti-diabetic Drugs (2018-2023)
-
Table China Preformulation Intermediates Production Volume by Region (2018-2023)
-
Table China Preformulation Intermediates Production Volume Share by Region (2018-2023)
-
Figure China Preformulation Intermediates Production Volume Share by Region (2018-2023)
-
Table China Preformulation Intermediates Production Value by Region (2018-2023)
-
Table China Preformulation Intermediates Production Value Share by Region (2018-2023)
-
Figure China Preformulation Intermediates Production Value Share by Region (2018-2023)
-
Table China Preformulation Intermediates Sales Volume by Region (2018-2023)
-
Table China Preformulation Intermediates Sales Volume Share by Region (2018-2023)
-
Figure China Preformulation Intermediates Sales Volume Share by Region (2018-2023)
-
Table China Preformulation Intermediates Sales Value by Region (2018-2023)
-
Table China Preformulation Intermediates Sales Value Share by Region (2018-2023)
-
Figure China Preformulation Intermediates Sales Value Share by Region (2018-2023)
-
Table North China Preformulation Intermediates Production Volume by Type (2018-2023)
-
Table North China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Figure North China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Table North China Preformulation Intermediates Sales Volume by Application (2018-2023)
-
Table North China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Figure North China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Table Central China Preformulation Intermediates Production Volume by Type (2018-2023)
-
Table Central China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Figure Central China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Table Central China Preformulation Intermediates Sales Volume by Application (2018-2023)
-
Table Central China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Figure Central China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Table South China Preformulation Intermediates Production Volume by Type (2018-2023)
-
Table South China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Figure South China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Table South China Preformulation Intermediates Sales Volume by Application (2018-2023)
-
Table South China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Figure South China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Table East China Preformulation Intermediates Production Volume by Type (2018-2023)
-
Table East China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Figure East China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Table East China Preformulation Intermediates Sales Volume by Application (2018-2023)
-
Table East China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Figure East China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Table Northeast China Preformulation Intermediates Production Volume by Type (2018-2023)
-
Table Northeast China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Figure Northeast China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Table Northeast China Preformulation Intermediates Sales Volume by Application (2018-2023)
-
Table Northeast China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Table Southwest China Preformulation Intermediates Production Volume by Type (2018-2023)
-
Table Southwest China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Figure Southwest China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Table Southwest China Preformulation Intermediates Sales Volume by Application (2018-2023)
-
Table Southwest China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Table Northwest China Preformulation Intermediates Production Volume by Type (2018-2023)
-
Table Northwest China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Figure Northwest China Preformulation Intermediates Production Volume Share by Type (2018-2023)
-
Table Northwest China Preformulation Intermediates Sales Volume by Application (2018-2023)
-
Table Northwest China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Preformulation Intermediates Sales Volume Share by Application (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Industries Ltd Company Profile
-
Table Teva Pharmaceutical Industries Ltd Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table Merck & Co Company Profile
-
Table Merck & Co Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Plc Company Profile
-
Table AstraZeneca Plc Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table Mylan, Inc Company Profile
-
Table Mylan, Inc Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
Table Novartis International AG Company Profile
-
Table Novartis International AG Preformulation Intermediates Revenue, Price and Gross (2018-2023)
-
